Hoth Therapeutics is a 505(b)(2) antimicrobial founded in 2017.
505(b)(2) antimicrobial
Hoth Therapeutics is a biopharmaceutical company dedicated to finding, investigating and developing early-stage therapeutics that will change the way diseases are managed and treated.
505(b)(2) antimicrobial
May 3, 2021
March 8, 2021